Pivoting After Health Canada’s CBD NHP Ruling
Why the Medical Channel is Now the Primary Path for CBD
The start of 2026 has brought a significant shift for the Canadian cannabis industry. In a move that surprised many stakeholders, Health Canada recently removed the long-awaited proposal for Natural Health Products (NHPs) containing CBD from its forward regulatory plan. For years, producers and consumers alike hoped for a “third stream” for CBD—one that would allow non-intoxicating cannabidiol to be sold on pharmacy shelves and in health food stores alongside vitamins and supplements. With that pathway now effectively stalled, the industry must pivot.
Here is what the removal of the CBD NHP proposal means for your business and how you can navigate this “Medical-First” landscape.
What Happened?
On January 8, 2026, industry news outlets reported that the regulatory framework designed to create a “pathway for health products containing cannabidiol” had been stripped from the government’s upcoming agenda. This follows years of consultations that began back in 2019.
Is the Medical Channel the Only Way Forward?
For producers focused on the wellness and therapeutic benefits of CBD, the answer is increasingly “yes.” Without an NHP pathway, CBD remains locked behind the same regulatory requirements as THC.
However, this isn’t necessarily a setback—it’s a clarification of the market. The Medical Cannabis Channel remains the only legal way for producers to provide CBD to patients with professional healthcare oversight and without the “recreational” stigma of the adult-use retail environment.
How AirMed Supports Your Pivot to Medical
If your business strategy relied on CBD NHPs, now is the time to double down on your medical sales infrastructure. AirMed was built from the ground up to support the complex requirements of medical cannabis sales in Canada.
1. The AirMed WordPress Medical Plugin
Your website needs to be more than a digital brochure; it needs to be a secure patient portal. Our WordPress Medical Plugin allows you to:
- Manage Patient Registration: Streamline the intake of medical documents and healthcare practitioner (HCP) authorizations.
- Secure Product Catalogs: Show your CBD-dominant products only to verified medical clients, ensuring you stay compliant with strict promotion and advertising regulations.
2. Encrypted Patient Messaging
Health-focused CBD consumers often have more questions than recreational users. AirMed provides secure, encrypted messaging between your staff and your clients, allowing you to provide high-touch customer service while protecting sensitive patient data.
3. Seamless Fulfillment & Shipping
Transitioning to a direct-to-patient model requires a robust logistics engine. AirMed integrates directly with carriers and fulfillment tools (like ShipStation) to ensure that your wellness-focused clients receive their CBD products discreetly and efficiently.
The Bottom Line
The removal of the CBD NHP proposal from the 2026 regulatory plan is a reminder of the volatility of the Canadian regulatory environment. However, the demand for high-quality, health-focused CBD has never been higher. By leveraging the Medical Channel, producers can bypass the uncertainty of the NHP path and start serving patients today.
Official Context: You can monitor the current Health Canada Forward Regulatory Plan for updates here: https://www.canada.ca/en/health-canada/corporate/about-health-canada/legislation-guidelines/acts-regulations/forward-regulatory-plan.html
Industry Commentary: StratCann reported that this move leaves CBD strictly under the Cannabis Act, rather than the Natural Health Products Regulations: https://stratcann.com/news/health-canada-removes-cbd-nhp-regulation-proposal-from-forward-regulatory-plan/
And for a demonstration of our medical plugin in action, please visit: https://airmeddemo.com/
The Rise of Craft and Quality: A Reflection on 2025
As the calendar turns from 2025 to 2026, it’s a natural time to pause and reflect on the evolution of our industry. This year has not only marked another milestone since legalization but has also demonstrated a profound shift in consumer expectations. We are moving past the initial phase of simply supplying volume; the market is maturing, demanding more sophistication and quality than ever before. This reflection leads us directly to the single most compelling growth strategy for the coming year: embracing the niche for premium, craft cannabis.
The Shift from Bulk to Boutique
Seven years into legalization, the Canadian cannabis consumer is no longer a novice. Consumers are sophisticated, educated, and increasingly selective. This maturation has fundamentally changed the domestic market, shifting the focus away from volume and toward quality, novelty, and differentiation.
While large producers compete on price in the value segment; smaller, nimble producers can find profitability in the premium craft segment. Consumers are demonstrating a willingness to pay a premium for products that offer a superior experience, unique strain profiles, and transparent production ethics.
Survival in 2026 requires more than just a licence; it requires a “Craft” badge. Provinces like Ontario (OCS) have set strict criteria for this designation, which micros are uniquely positioned to meet. By meeting these standards, micros can charge a premium that offsets their higher cost-of-production compared to “Standard” producers who rely on machine-trimming and volume.
The Craft Advantage
Recent regulatory adjustments by Health Canada are directly enabling this shift by reducing red tape and empowering smaller operators through expanded micro licensing, co-packing and flexible labelling.
To capitalize on the demand for craft and quality, producers should focus on:
- Cultivation Excellence: Embrace traditional, hands-on methods such as hand-trimming, hang-drying, and specialized curing processes that preserve terpene profiles and visual appeal.
- Genetics and Uniqueness: Differentiate your brand by cultivating rare or unique genetics that can’t be found on every store shelf. Consumer loyalty is built on exceptional, repeatable experiences.
- Authentic Storytelling: Consumers want to know where their product comes from. Be transparent about your grow methods, your team, and the care that goes into each batch. This authenticity fosters trust and commands a premium price point.
The era of undifferentiated, mass-market cannabis is fading. The future belongs to the producers who are committed to quality and who understand that, in a competitive market, craftsmanship is the ultimate differentiator.
To read more about the micro movement in Canada, read this article on the Stracann website: https://stratcann.com/news/micros-continue-to-be-the-most-popular-cannabis-licence-type-in-2025/
AirMed was designed for just such craftsmanship and commitment to quality. For more information visit our Software page.
And for information on our micro licensing programme visit: https://www.airmedmicro.com/
Happy New Year!
As we close the book on 2025 and welcome a new year, the team at AirMed pauses to reflect on the depth and complexity of Canada’s cannabis journey.
Turning the calendar page to a new year, we take this moment to recognize the perseverance demonstrated by all members of the Canadian cannabis community.
The New Year, as always, offers an opportunity for a fresh start and renewed focus. We send our best wishes for a future filled with sound insights and resilience for you and your organizations.
May your year be marked by strength, clarity, and well-deserved moments of success. From all of us at AirMed, we wish you a Happy New Year!
Season’s Greetings
As the holiday season arrives, the entire team at AirMed extends our deepest gratitude to all our clients and industry partners. Your support, collaboration, and trust have been truly invaluable.
This season is a time for connection and appreciation. We value the relationships we’ve built and the shared journey we’ve undertaken.
We hope this time brings you a chance to rest and renew your spirit. May the days ahead be filled with warmth and peace.
Wishing you a joyful holiday season and a prosperous 2025!
All the best from the team at AirMed.
Grow Up Vancouver 2026 Conference: Jan 20-21
The GrowUp Conference & Expo, returning to the Vancouver Convention Centre from January 19-21, 2026, offers Canada’s premier B2B platform for strategic growth and innovation.
GrowUp is more than just a trade show; it is an intensive three-day forum designed to connect every step of the supply chain. With an agenda featuring over 60 sessions and 100+ industry experts, the event is a powerhouse of specialized knowledge.
For producers, the benefits are clear and directly tied to profitability and market expansion:
1. Unlock Retail Access: Utilize the Brands & Buyers Zone and dedicated Speed Networking sessions to meet directly with hundreds of retail buyers, budtenders, and purchasing agents from B.C.’s dynamic market—a vital opportunity to secure listings and build brand relationships.
2. Master Advanced Cultivation: The Masterclass Technical Series provides in-depth education on cutting-edge cultivation science, genetics, and extraction technology, ensuring your team is operating with maximum efficiency and quality. Look for the CANNA Breeder & Genetics Zone to explore new strains.
3. Future-Proof Your Strategy: The Executive Summit (Jan. 19th) focuses on high-level strategy, profitability models, global regulatory trends, and investment opportunities—critical insights for executive-level decision-makers.
Whether you’re a micro-cultivator seeking new genetics or an LP aiming to secure major retail contracts, GrowUp is the place to solidify your 2026 business plan and connect with key players across the industry.
For more information visit: https://growupconference.com/
Profile: Ontario Cannabis Association
The Ontario Cannabis Association (OCA) is a non-profit organization that represents licensed producers and processors in the province. The association’s mission is to be a collective voice for its members, working to strengthen the cannabis industry in Ontario using the guiding principles: Unite, Advocate, and Elevate.
The OCA’s work is based on several key pillars:
Advocacy: It actively champions the interests of its members by engaging with government officials and the Ontario Cannabis Store (OCS) to influence policy and regulation.
Collaboration: The association fosters partnerships with other organizations, including the Ontario Farmers Association and legacy market participants, to help them transition into the legal market.
Business Support: The OCA facilitates networking and knowledge-sharing among its members and leverages its relationships with suppliers to secure exclusive benefits and discounts.
Quality Assurance: The organization is developing a quality assurance labeling system to distinguish its members’ products and promote high standards of business practices and product quality.
The association is working to build a more inclusive, diverse, and economical cannabis industry in Ontario while ensuring the long-term success of its members and establishing a trusted and reputable legal market.
For more information please visit:
https://www.ontariocannabisassociation.ca/
Certified to Export Webinar: December 9, 2025
As the Canadian cannabis market matures, the next frontier for growth is unequivocally international. For Licensed Producers (LPs) looking to move beyond domestic competition and access new, high-value medical markets, understanding global certification is non-negotiable.
Join Control Union Canada on Tuesday, December 9, 2025, at 2:00 pm Eastern Time/11 am Pacific Time for a free webinar, “Certified to Export: Connecting Canadian Cannabis to the World.” This session is designed for both micro and large producers who need a clear roadmap for international trade.
The expert-led discussion will dive deep into the crucial steps required to transition from Health Canada compliance to meeting the stringent demands of global buyers. Attendees will learn:
- How to bridge the gap between Canadian standards and international certifications like GACP (Good Agricultural Collection Practices), IMC GAP, and GMP (Good Manufacturing Practices).
- The essential role that quality assurance and stability testing play in securing international contracts.
- Best practices for export logistics, including the function of tollers, to ensure smooth distribution.
- What global buyers specifically expect from Canadian suppliers to gain credibility and market access.
Control Union Canada is a third-party certification body that provides international compliance audits. The organization helps Licensed Producers (LPs) achieve globally recognized standards like Good Agricultural and Collection Practices (GACP) and Good Manufacturing Practices (GMP), which are required to export medical cannabis to high-value markets like the EU, Israel, and Australia.
For more information including how to register visit:
https://northamerica.controlunion.com/certified-to-export-connecting-canadian-cannabis-to-the-world/
Beyond Borders: Positioning Canadian Cannabis for the Global Export Market
The Global Opportunity: Why Canadian Cannabis is Primed for Export Growth
Canada has long held a first-mover advantage in the global cannabis ecosystem. Since federal legalization, Canadian producers have established world-class cultivation and processing standards that are highly valued on the international stage. As more countries open their doors to medical cannabis—particularly in Europe, Australia, and Israel—exporting is becoming a vital strategy for those looking to diversify revenue and mitigate challenges in the saturated domestic market.
The demand for pharmaceutical-grade cannabis continues to rise globally. For Canadians, the international stage is not just a secondary market; it’s a critical component of long-term economic sustainability.
Bridging the Compliance Gap: From Health Canada to the World
While Health Canada’s licensing is the foundation, accessing most international markets requires an extra layer of compliance, most notably Good Manufacturing Practices (GMP) certification. The critical points in this process are as follows.
- Certification: For producers targeting Europe, obtaining EU-GMP certification or an equivalent international standard (such as IMC GAP/GACP) is essential. This signals to global buyers that your product meets the strict quality assurance and control standards required for medical products.
- Leverage Quality: Canadian-produced cannabis is often seen as a premium product. Producers should lean into this advantage by emphasizing specialized genetics, consistency, and stability testing, which are paramount for long-term supply contracts.
- Strategic Partnerships: Working with GMP-certified distributors, logistics experts, and experienced global consultants can streamline the complex process of international customs, tariffs, and differing regulatory requirements across jurisdictions.
By intentionally building an export-ready operation today, Canadian producers can move beyond domestic competition and solidify their role as reliable, high-quality suppliers in the expanding global market. The time to look outward is now.
AirMed was designed for export markets and meets GMP and GACP standards.
For more information visit our Software page.
Or visit our Compliance page.
Honoring Freedom: How Legal Cannabis Reflects the Society Canadian Veterans Fought to Protect
On the 11th hour of the 11th day of the 11th month, Canada falls silent.
Remembrance Day is a solemn occasion where we pause to honour the courage, dedication, and profound sacrifice of all Canadian veterans. They risked everything to secure the fundamental values we hold dear: freedom, democracy, and the enviable quality of life we enjoy today.
As a nation that values progress and liberty, our societal landscape is constantly evolving. And in recent years, one of the most significant shifts—the legalization of cannabis—has created a surprising, yet meaningful, link to our duty of care for those who served.
This Remembrance Day, we reflect not just on the battles won abroad, but on the freedoms secured at home.
The legalization and regulation of cannabis through the Cannabis Act in 2018 was a landmark moment, rooted in the very freedoms our veterans defended. The debate was animated by a “philosophically liberal approach,” the core idea being that adults in a free society should have the liberty to make informed choices for themselves.
While this shift had several profound real-world consequences, in general legalization represents the kind of social progress and thoughtful governance that a free and democratic society—the kind veterans fought for—is uniquely positioned to achieve.
For some Canadian veterans, the availability of legal, regulated cannabis is far more than a matter of personal choice—it is a critical aspect of modern healthcare and an essential component of the national duty of care.
Veterans are disproportionately impacted by complex, often co-occurring, conditions, including Post-Traumatic Stress Disorder (PTSD), chronic pain, anxiety, and insomnia. For many, conventional treatments have failed to provide relief.
This is where the regulated cannabis industry and public policy intersect with the deepest respect for service by providing a medically recognized option.
As we observe the two minutes of silence at 11:00 a.m. on November 11th, let the poppy on our lapel remind us of the immense sacrifices made for our freedom to choose, to progress, and to change our society for the better.
For more information on veterans health in Canada visit https://missionvav.com/
You can also read our post from last year that talked about a report on veterans health from The Mental Health Commission of Canada (MHCC): https://airmedcloud.com/mhcc-veterans-cannabis-report/
Report: Canada's Cannabis Sector is Mainstream
Seven years after legalization, the cannabis industry has fully integrated into Canadian society, moving from niche to mainstream consumer choice according to a new report. A national survey by Abacus Data reveals that not only is use widespread, but Canadians across the political spectrum see the sector as a valuable economic engine and are ready to see regulations modernized to fuel its growth.
According to the survey, Cannabis is part of everyday life. The data clearly shows that cannabis use is no longer a subculture. More than one in three Canadian adults report using cannabis in the past six months, with that number rising to 50% for those under 45. Cannabis is being consumed in diverse forms, with 25% of Canadians using edibles recently. Notably, the preference for cannabis is challenging alcohol: 30% of users say they prefer cannabis over alcohol, with another 29% viewing the two equally.
Canadians view the legal cannabis industry as a significant economic contributor, with a strong majority of 59% agreeing it’s important to the national economy. This perspective holds true across regions and political affiliations. This broad support translates into a clear message for policymakers.
Canadians are looking for the federal government to move beyond simple compliance and focus on growth. When asked about priorities, respondents want economic departments (like Industry or Agriculture) involved in policy decisions (47%) and tougher enforcement against the illegal market (43%).
There is also strong public appetite for emerging product categories. A majority (57%) is open to federal investment in the growth of new products like cannabis beverages, edibles, and wellness items.
Looking toward the future, over 70% of Canadians view the creation of tens of thousands of new domestic jobs and Canada becoming a global leader in wellness-focused cannabis products as a positive outcome.
The Abacus Data report concludes that the legal cannabis industry has a solid social license and visible economic value.
Abacus Data is a Canadian polling and market research firm based in Ottawa, Ontario.
For more on this report visit: https://abacusdata.ca/cannabis-is-mainstream-public-support-is-strong-and-canadians-want-the-sector-to-grow/
MJBiz Conference: Dec 2-5 in Las Vegas
MJBizCon, the largest cannabis business event in the U.S.A., brings together entrepreneurs, retailers, investors, and cannabis professionals from around the world. Whether you’re looking to scale your business, make informed business decisions, source products and services, or identify emerging market trends, MJBizCon is where the global cannabis industry comes to connect and grow.
- Explore 1,000+ exhibitors featuring cutting-edge products, technology, and services.
- Gain insights from 100+ experts in finance, science, marketing, policy, and operations.
- Network with 20,000+ professionals representing every corner of the global cannabis industry.
- Attend Pre-Show Forums for deep dives into finance, marketing, science, and associations.
This live event is being held December 2nd through 5th, 2025 at the Las Vegas Convention Center.
For more information visit: https://mjbizconference.com/
Budget-friendly Cannabis Management
In a previous post, we announced AirMed Micro, our new budget-friendly cannabis management licensing option.
But why is AirMed the ideal choice for micros? Because you only pay for what you need right now. Modular pricing means you customize the system to your needs and only pay for what you use. The result is software priced significantly lower than other cannabis management systems, making it an ideal choice for micro cultivators operating on a budget.
Built on the award-winning AirMed platform, AirMed Micro lets you utilize and pay for only the modules you need at the time, with the option to add more later. Scale up by adding new features when your business demands such as optional integrations with third-party systems like Quickbooks and Shipstation, which cut costs and consolidate all aspects of your operation in one convenient platform.
This flexibility makes AirMed Micro an investment in the future of your operations. Our pricing structure offers long-term cost savings while still delivering top-tier features.
To learn more about AirMed Micro, please visit our new AirMed Micro website including pricing and free trial information: https://www.airmedmicro.com/
If you have questions not answered on the site, contact our sales department using the Request Demo link at the top of the page. You can also drop us a line at info @ airmed dot ca or call 1-877-313-2442 toll free.
Profile: Alberta Cannabis Micro Licence Association
The Alberta Cannabis Micro Licence Association (ACMLA) is a non-profit organization that provides a unified voice for small-scale cannabis producers in Alberta. The association’s membership is comprised of micro-license holders, applicants, and other industry supporters.
The ACMLA’s mission is centered on advocacy, education, and collaboration. The group works directly with all levels of government to support the growth of the province’s craft cannabis sector. Key goals include shaping the industry’s future through policy reform, promoting low-cost sales channels like farm-gate operations, and reducing barriers for new entrants. The association also focuses on improving business practices and quality control for its members by sharing resources and best practices.
Beyond industry support, the ACMLA aims to foster broader economic opportunities, such as promoting cannabis tourism within Alberta. The association is also dedicated to combating the stigma surrounding cannabis through evidence-based education. By uniting its members, the ACMLA strives to create a more competitive and vibrant cannabis landscape that benefits small producers and the broader community.
For more information please visit:
https://acmla.ca/
Cannabis at the Crossroads: Oct 30 in Ottawa
Hosted by The Pearson Centre, Cannabis at the Crossroads is an exclusive panel-style event where the most influential voices from public and private sectors will come together to discuss and debate the most pressing issues facing the Canadian cannabis industry.
This year’s conference will take a closer look at the most pressing issues facing the cannabis industry in Canada and:
- Explore how Canadians view legalization seven years on, with national polling insights into public acceptance and support for the sector.
- Examine the current excise model and investigate ways to eliminate internal trade barriers to strengthen the overall system so that it delivers on the promise of legalized cannabis.
- Highlight the economic opportunity, underscoring the industry’s role in creating jobs, driving investment, and contributing to growth both at home and abroad.
- Discuss how Canadian companies can overcome trade and regulatory barriers to succeed.
This conference is designed for professionals who are passionate about the cannabis industry’s growth and sustainability. Whether you’re involved in policy, business, or research, your voice is crucial to the conversation.
For more information visit: https://www.cannabis-council.ca/industry-news/cannabis-at-the-crossroads
AirMed Introduces Scaled-down Version for Micros
To meet market demands, we’re now offering a new licensing option for micro cultivators that provides an affordable alternative to higher-priced ERPs.
This new version relies on AirMed’s modular design, letting clients license only the modules they need right now. The micro option delivers a scaled-down version designed specifically for small operations.
Micro producers get an intuitive and affordable cannabis management solution that simplifies the complexities of cultivation, inventory management, and compliance. But the system can grow with you. We provide the ability to add functionality when needed without having to switch to a new software system. You can start with the core features and add modules as your production scale and budget increases.
Designed to improve efficiency in smaller operations, AirMed Micro integrates all essential aspects of cannabis cultivation into one user-friendly platform. But we’ve simplified data entry with intuitive graphical interfaces and minimal manual input to reduce overhead as well as the potential for errors.
Our real-time dashboard lets you track everything from source materials to sales orders instantly and helps you make informed decisions to enhance quality and optimize inventory.
Offering a streamlined version of the full AirMed platform, AirMed Micro provides the essential features needed to ensure complete operational control with optional add-ons to suit growing needs.
Easy to use, fully compliant, with fast set up and flexible billing, our new modular licensing makes AirMed ideal for micros on a budget.
To learn more about AirMed Micro, please visit our new AirMed Micro website including pricing and free trial information: https://www.airmedmicro.com/
If you have questions not answered on the site, contact our sales department using the Request Demo link at the top of the page. You can also drop us a line at info @ airmed dot ca or call 1-877-313-2442 toll free.
CannExpo 2025: Oct 24-25 in Toronto
CannExpo is the ultimate event for professionals, consumers, budtenders, LPs, start-ups, retailers, investors, and curious newcomers in the cannabis retail sector.
Dive into the heart of the cannabis industry, and explore new brands, connect with the cannabis community, and learn from industry leaders at CannExpo.
Postponed from March of this year, the event is now being held October 24 and 25 at the Queen Elizabeth Building, Exhibition Place, Toronto.
For more information visit: https://cannexpo.ca/
Canadian Greenhouse Conference 2025: Oct 8-9 in Niagara Falls
With the theme “Harvesting Resilience,” this year’s Canadian Greenhouse Conference promises two days of informative, motivating sessions and a large trade show.
The Canadian Greenhouse Conference is Canada’s leading event for commercial greenhouse flower, vegetable, cannabis, berry and nursery growers. Don’t miss this ultimate connection point for growers, suppliers and research partners.
CGC is a not-for-profit corporation and the conference attracts attendees from across North America, gathers experts from around the world and showcases innovative techniques, research, products and technology.
For more information visit: https://www.canadiangreenhouseconference.com/
Profile: BC Cannabis Alliance
The BC Cannabis Alliance (BCCA) is a non-profit organization that serves as a collective voice for British Columbia’s licensed craft cannabis producers. Rooted in the province’s tradition of high-quality, small-batch cannabis, the BCCA advocates for a sustainable and thriving industry that supports rural economies and creates skilled jobs.
The alliance operates on a cooperative model, with a mission to help maintain BC’s status as a global leader in cannabis innovation. It works to provide small and medium-sized producers with a safe, legal, and sustainable alternative to the illicit market. Key goals include accelerating market access, establishing a retail network for its members, and achieving economies of scale to ensure these producers can compete with larger corporations.
A core function of the BCCA is government advocacy. The organization works to reform provincial and federal policies by addressing issues like excessive taxation, regulatory burdens, and competition from the unregulated market. It actively pushes for changes such as a more equitable excise tax structure, direct delivery reporting reforms, and grants for cannabis manufacturing. By championing causes like fair farm status exemptions and aligning licensing fees with other agricultural sectors, the BCCA aims to create a more supportive environment for BC’s craft cannabis industry.
For more information including how you can help, visit:
https://www.bccannabisalliance.com/
AirMed and Cannabis 2.0
In our last post, we discussed how Cannabis 2.0 is changing the Canadian cannabis industry, but how does AirMed power this product innovation?
With the legalization of derivative products like edibles, vapes, and topicals, a world of opportunity has opened up for licensed producers. To thrive in this evolving market, Canadian companies—from large-scale operations to nimble micro-processors—need a flexible cannabis management system. This is where AirMed comes in BY providing a comprehensive solution designed to handle the complexities of Cannabis 2.0 while ensuring compliance every step of the way.
Meeting the Unique Challenges of Cannabis 2.0
Producing derivative cannabis products is more complex than simply growing and packaging dried flower. It involves intricate manufacturing processes, strict quality control, and detailed record-keeping. AirMed software is specifically designed to handle these challenges.
Manufacturing and Processing: AirMed offers unique workflows for each product type, from edibles and beverages to vapes and concentrates. The system tracks every step of your production process, from sourcing raw materials to extraction and final packaging. This ensures you have a complete audit trail for Health Canada inspections.
Inventory and Batch Tracking: With Cannabis 2.0 products, precision is everything. AirMed tracks weights to five decimal places and allows you to manage batches and lots with unique identifiers. This is critical for maintaining consistency and accuracy, especially with products that have a regulated THC and CBD content per package. Our software supports the creation of discrete units like pre-rolls and gel caps, as well as bulk products for sale to other licensed producers.
Compliance and Reporting: The regulations for Cannabis 2.0 products are extensive, covering everything from ingredient lists to packaging requirements and THC limits. AirMed automates the data collection for Health Canada’s Cannabis Tracking and Licensing System (CTLS) reports, simplifying the compliance process. Our software ensures you can meet all federal, provincial, and even international standards (like the USA’s FDA 21 CFR Part 11 and EU GMP).
The Bottom Line: A Solution to Cultivate Success
The Cannabis 2.0 market is driven by consumer demand for diverse and innovative products. By using AirMed, Canadian licensed producers can streamline their operations, reduce compliance risks, and focus on what they do best: creating high-quality cannabis products.
Whether you are a large-scale standard processor introducing a new line of infused products or a micro-cultivator crafting artisanal strains, the AirMed platform offers the tools you need. Our software provides the foundation of efficiency and control needed to not only survive but to thrive in this exciting new chapter of the Canadian cannabis industry.
To learn more about how AirMed powers Cannabis 2.0 innovation for Canadian producers, visit our Software page.
Cannabis 2.0 in Canada
“Cannabis 2.0” describes the expansion of the legal Canadian cannabis market beyond the initial offerings of dried flower, oils, and seeds. This new era is the result of the legalization of derivative products like edibles, vapes, beverages, topicals, and concentrates in Canada, which happened back in 2019. The shift has been significant in the Canadian industry, as it has attracted a new segment of consumers who may not be interested in smoking or vaping.
Consumer Behavior
Initially, dried flower dominated the cannabis market, but consumer tastes are evolving. New users in particular are seeking discreet, convenient, and predictable ways to consume cannabis. Cannabis 2.0 products directly address this demand. Edibles like gummies and chocolates as well as ready-to-drink beverages offer a familiar format, making them appealing to those who were previously hesitant to try cannabis. This trend is causing a gradual decline in the market share of dried flower, while other categories, especially vapes and edibles, are seeing significant growth.
Product Innovation and Market Diversification
The rise of Cannabis 2.0 has sparked a wave of innovation. Canadian licensed producers are developing a wide variety of products with different cannabinoid profiles (THC, CBD, and CBN) and terpene blends. This lets them create products with targeted effects, such as those for relaxation, sleep, or creativity. Some of the most exciting innovations include:
- Fast-acting edibles and beverages: Technology has been developed to create products that deliver effects much faster than traditional edibles, which often took hours to kick in. This is a game-changer for consumer experience and predictability.
- Minor cannabinoid products: Beyond THC and CBD, producers are now creating products that highlight minor cannabinoids like CBN (cannabinol) for sleep, or CBG (cannabigerol) for its anti-inflammatory properties.
- Craft and gourmet products: The market is seeing a rise in high-end, carefully crafted products, such as artisanal chocolates and specialty beverages, that are designed to compete with premium mainstream goods.
Attracting a Broader Audience
The diverse product offerings of Cannabis 2.0 are helping to destigmatize cannabis use and attract new customers. Many consumers who are not traditional cannabis users are drawn to topicals for pain relief, beverages as an alternative to alcohol, or low-dose edibles for a gentle introduction.
This expansion of the consumer base is vital for the long-term health and growth of the legal industry. It’s moving cannabis out of the shadows and into the mainstream, positioning it as a lifestyle product for a variety of purposes and demographics.
For more information visit our Software page.